PY314 is a CHO-expressed humanized monoclonal antibody targeting TREM2 with antitumor activity for the study of metastatic renal cell carcinoma.

MSC-1 (Anti-LIF Antibody) is a humanized anti-leukemia inhibitory factor (LIF) monoclonal antibody that acquires anti-tumor and pro-inflammatory functions in a homozygous colon cancer mouse model and can be used to study advanced solid tumors.

Anti-Beta Klotho Antibody (Fazpilodemab) is a monoclonal antibody that targets Beta Klotho. The sequence is referenced from Fazpilodemab.

Atrosab is a humanized IgG1 antibody targeting TNFR1, inhibiting TNF-mediated apoptosis, and can be used to study inflammatory and neurodegenerative diseases.

PF-06342674 is a humanized monoclonal antibody targeting the IL-7 receptor-α, with immunoregulatory activity, used in Type 1 diabetes research.

VGX100 is a humanized antibody targeting VEGFC for the study of solid tumors.

Turmetabart is an IgG1 monoclonal antibody targeting SEZ6, which can be used for the synthesis of antibody-drug conjugates (ADCs), such as ABBV-011.

HuMax-IL8 (MDX 018) is a humanized anti-IL-8 monoclonal antibody for the study of metastatic or unresectable solid tumors.

AMG 108 (MEDI 8968) is a fully human monoclonal antibody targeting IL-1R1, used in rheumatoid arthritis research.

TNM001 is an anti-RSV fully humanized monoclonal antibody for the study of lower respiratory tract disease due to RSV infection.

MEDI-578 is a CHO-expressed humanized monoclonal antibody targeting NGF/bNGF for the study of neurological and immune system disorders.

U3-1565 (Anti-HB-EGF antibody) is an antibody targeting HB-EGF with potential anti-tumor activity, used in the study of advanced solid tumors.

ASK8007 is a humanized antibody that blocks bone bridging proteins and can be used to study rheumatoid arthritis.

Anti-MAGEA3 Antibody is a humanized anti-MAGEA3 antibody expressed by CHO cells. Anti-MAGEA3 Antibody can be used for activity assays, functional studies, binding affinity analysis, and other applications, serving as an essential tool in biological research.

MEDI-3617 is a humanized antibody targeting Ang2/ANGPT2/Angiopoietin2, inhibits loss of endothelial/smooth muscle cell contact, and can be used to study cardiovascular disease.

COM701 is a humanized monoclonal antibody targeting PVRIG, an immune checkpoint inhibitor with anti-tumor activity, used in liver cancer research.

GSK3050002 (E-6071) is a humanized antibody targeting CCL20, which can be used to study immune system diseases and digestive system diseases.

ABX-IL8 is a humanized antibody targeting IL-8, which interferes with the tubular formation of human umbilical vein endothelial cells, inhibiting angiogenesis, tumor growth, and metastasis in human melanoma.

CM-24 (MK-6018) is a humanized antibody targeting CEACAM1, an effective blocker of the CEACAM1-CEACAM1 interaction between cells, reversing the inhibition of activated lymphocytes by restoring ZAP70 phosphorylation, which can be used to study pancreatic cancer and colon adenocarcinoma.

Anti-Human IL-17A is a fully human anti- interleukin-17A monoclonal antibody. Anti-Human IL-17A can be used for research in psoriasis pathogenesis [1] .

ATG-031 is a high affinity humanized anti-CD24 monoclonal antibody that shows antitumor activity in vitro and in vivo.ATG-031 blocks the CD24-Siglec10 axis in the TME.ATG-031 can be used to study non-Hodgkin's lymphomas and to modulate the tumor microenvironment.

Anti-ETBR Antibody (DEDN6526A Naked Antibody) is a highly specific monoclonal antibody targeting the endothelin B receptor (ETBR) and serves as the antibody for the ADC molecule DEDN6526A. DEDN6526A (RG-7636) is a humanized ETBR-targeting antibody-drug conjugate developed for melanoma research.

Anti-CD33 Antibody (IMGN-779 Naked Antibody) is a humanized antibody targeting CD33 with antileukemic activity, which can be used to study leukemia.

Anti-IL-12 p70 Antibody (20C2) is an anti-human IL-12 p70 monoclonal antibody of the IgG1 isotype, and it acts by suppressing the production of interferon-gamma. Anti-IL-12 p70 Antibody (20C2) is applicable for research studies investigating inflammatory conditions where IL-12 signaling contributes to disease pathogenesis. Anti-IL-12 p70 Antibody (20C2) is recommended to be paired with an appropriate isotype control, specifically Rat IgG1 kappa, Isotype Control.